Cigna's strong growth potential, Evernorth expansion, and stock buybacks make it undervalued. Click here to find out why CI ...
Progyny Inc (PGNY) reports strong financial performance with record ART cycles and strategic expansions, despite challenges ...
Health insurance company Cigna (NYSE:CI) announced better-than-expected revenue in Q4 CY2024, with sales up 28.4% year on year to $65.65 billion. The company expects the full year’s revenue to ...
Ladies and gentlemen, thank you for standing by for the Cigna Group’s Fourth Quarter 2024 Results Review. At this time all callers are in a listen-only mode. We will conduct a question-and ...
Cigna's actual EPS of $6.64 for Q4 fell short of the forecasted $7.79, representing a 14.7% miss. However, revenue of $65.65 billion surpassed expectations by 3.9%, indicating strong top-line ...
Cigna Corp (NYSE:CI) reported its fourth-quarter 2024 earnings, revealing a notable miss on earnings per share (EPS) despite surpassing revenue expectations. The company's stock reacted negatively in ...
Cigna reports fourth-quarter revenue of $65.68 billion, beating analyst estimates of $63.36 billion. Cigna reports fourth-quarter adjusted earnings of $6.64 per share, missing analyst estimates of ...
Health insurance company Cigna (NYSE:CI) announced better-than-expected revenue in Q4 CY2024, with sales up 28.4% year on year to $65.65 billion. The company expects the full year’s revenue to be ...
The Cigna Group CI reported fourth-quarter 2024 adjusted earnings per share (EPS) of $6.64, which missed the Zacks Consensus Estimate by 15.2%. The bottom line declined 2.2% year over year.
David Cordani; Chairman of the Board, President, Chief Executive Officer; Cigna Group Brian Evanko; Chief Financial Officer, Executive Vice President, President and Chief Executive Office - Cigna ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results